Norbert J. Tripolt

2.3k total citations
45 papers, 854 citations indexed

About

Norbert J. Tripolt is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Molecular Biology. According to data from OpenAlex, Norbert J. Tripolt has authored 45 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Physiology and 12 papers in Molecular Biology. Recurrent topics in Norbert J. Tripolt's work include Diabetes Treatment and Management (14 papers), Diet and metabolism studies (13 papers) and Diabetes Management and Research (11 papers). Norbert J. Tripolt is often cited by papers focused on Diabetes Treatment and Management (14 papers), Diet and metabolism studies (13 papers) and Diabetes Management and Research (11 papers). Norbert J. Tripolt collaborates with scholars based in Austria, United Arab Emirates and Germany. Norbert J. Tripolt's co-authors include Harald Sourij, Vanessa Stadlbauer, Bettina Leber, Thomas R. Pieber, M Eder, Thomas C. Wascher, W. Graninger, Florentine Moazedi‐Fuerst, Peter N. Pferschy and Faisal Aziz and has published in prestigious journals such as PLoS ONE, Diabetes Care and Diabetes.

In The Last Decade

Norbert J. Tripolt

42 papers receiving 835 citations

Peers

Norbert J. Tripolt
Norbert J. Tripolt
Citations per year, relative to Norbert J. Tripolt Norbert J. Tripolt (= 1×) peers Kamel S. Kamel

Countries citing papers authored by Norbert J. Tripolt

Since Specialization
Citations

This map shows the geographic impact of Norbert J. Tripolt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert J. Tripolt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert J. Tripolt more than expected).

Fields of papers citing papers by Norbert J. Tripolt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert J. Tripolt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert J. Tripolt. The network helps show where Norbert J. Tripolt may publish in the future.

Co-authorship network of co-authors of Norbert J. Tripolt

This figure shows the co-authorship network connecting the top 25 collaborators of Norbert J. Tripolt. A scholar is included among the top collaborators of Norbert J. Tripolt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norbert J. Tripolt. Norbert J. Tripolt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Benedikt, Martin, Faisal Aziz, Ewald Kolesnik, et al.. (2024). Impact of baseline ECG characteristics on changes in cardiac biomarkers and echocardiographic metrices after acute myocardial infarction treated with Empagliflozin. Scientific Reports. 14(1). 15083–15083. 1 indexed citations
4.
Aziz, Faisal, Norbert J. Tripolt, Peter N. Pferschy, et al.. (2024). Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial. Cardiovascular Diabetology. 23(1). 145–145. 10 indexed citations
5.
Pferschy, Peter N., Norbert J. Tripolt, Hansjörg Habisch, et al.. (2024). Effects of dietary interventions and intermittent fasting on HDL function in obese individuals with T2DM: a randomized controlled trial. Cardiovascular Diabetology. 23(1). 339–339. 4 indexed citations
6.
Lewinski, Dirk von, Ewald Kolesnik, Faisal Aziz, et al.. (2023). Timing of SGLT2i initiation after acute myocardial infarction. Cardiovascular Diabetology. 22(1). 269–269. 12 indexed citations
7.
Benedikt, Martin, Harald Mangge, Faisal Aziz, et al.. (2023). Impact of the SGLT2-inhibitor empagliflozin on inflammatory biomarkers after acute myocardial infarction – a post-hoc analysis of the EMMY trial. Cardiovascular Diabetology. 22(1). 166–166. 21 indexed citations
8.
Aziz, Faisal, Norbert J. Tripolt, Peter N. Pferschy, et al.. (2023). Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial. Cardiovascular Diabetology. 22(1). 184–184. 11 indexed citations
9.
Moser, Othmar, Alexander Müller, Felix Aberer, et al.. (2022). Comparison of Insulin Glargine 300 U/mL and Insulin Degludec 100 U/mL Around Spontaneous Exercise Sessions in Adults with Type 1 Diabetes: A Randomized Cross-Over Trial (ULTRAFLEXI-1 Study). Diabetes Technology & Therapeutics. 25(3). 161–168. 7 indexed citations
10.
Eyileten, Ceren, Zofia Wicik, Faisal Aziz, et al.. (2022). Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study. Cardiovascular Diabetology. 21(1). 79–79. 15 indexed citations
11.
Moser, Othmar, Max L. Eckstein, Alexander Mueller, et al.. (2021). Impact of a Single 36 Hours Prolonged Fasting Period in Adults With Type 1 Diabetes – A Cross-Over Controlled Trial. Frontiers in Endocrinology. 12. 656346–656346. 9 indexed citations
12.
Horvath, Angela, Bettina Leber, Nicole Feldbacher, et al.. (2019). Effects of a multispecies synbiotic on glucose metabolism, lipid marker, gut microbiome composition, gut permeability, and quality of life in diabesity: a randomized, double-blind, placebo-controlled pilot study. European Journal of Nutrition. 59(7). 2969–2983. 71 indexed citations
13.
Tripolt, Norbert J., Felix Aberer, Jasmin Url, et al.. (2018). Impact of Duodeno-Jejunal Bypass Liner (EndoBarrierTM) Implantation on Insulin Sensitivity in Patients with Type 2 Diabetes Mellitus (T2DM): A Study Protocol for a Pilot Trial. Diabetes Therapy. 10(1). 299–309. 4 indexed citations
14.
Tripolt, Norbert J., Felix Aberer, Regina Riedl, et al.. (2018). Effects of linagliptin on endothelial function and postprandial lipids in coronary artery disease patients with early diabetes: a randomized, placebo-controlled, double-blind trial. Cardiovascular Diabetology. 17(1). 71–71. 11 indexed citations
16.
Tripolt, Norbert J., et al.. (2014). Multiple risk factor intervention reduces carotid atherosclerosis in patients with type 2 diabetes. Cardiovascular Diabetology. 13(1). 95–95. 18 indexed citations
18.
Moazedi‐Fuerst, Florentine, Rudolf Zechner, Norbert J. Tripolt, et al.. (2012). Pulmonary echography in systemic sclerosis. Clinical Rheumatology. 31(11). 1621–1625. 30 indexed citations
19.
Leber, Bettina, Norbert J. Tripolt, M Eder, et al.. (2012). The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study. European Journal of Clinical Nutrition. 66(10). 1110–1115. 100 indexed citations
20.
Tripolt, Norbert J. & Harald Sourij. (2010). Diabetes mellitus und endotheliale Dysfunktion. Journal für Kardiologie (Krause & Pachernegg GmbH). 3(2). 20–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026